Benitec Biopharma, Inc.
Clinical trials sponsored by Benitec Biopharma, Inc., explained in plain language.
Now part of
Benitec Biopharma Inc.
BNTC
NASDAQ
Benitec Biopharma is a clinical-stage gene therapy company using RNA interference to treat chronic diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.